Endovascular thrombectomy (EVT) does not lead to better outcomes at 90 days compared with usual care or best medical treatment for patients with acute ischemic stroke due to medium vessel occlusion.

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...

The following is a summary of “Hyponatremia is associated with malignant brain edema after mechanical thrombectomy in acute ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

Patients in the endovascular therapy group achieved greater functional outcomes at 90 days. 2. Endovascular therapy resulted in significantly decreased disability and overall mortality. Evidence ...

Injecting tenecteplase into the artery after clot removal helps improve recovery in stroke survivors by enhancing blood flow ...

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...